Neonatal effects of maternal therapy with tricyclic antidepressant drugs Sir, We read with interest the letter by Ben Musa and Smith (Archives, 1979, 54, 405) on withdrawal symptoms, mainly instability of body temperature and jitterness, in a neonate affected by maternal clomipramine intake.
In 1972 we reported on three term infants born of mothers who took imipramine during pregnancy.' Transient, alternating episodes of hypokinesia and jerky movements were seen in all three. One baby convulsed on day 2. Transient tachypnoea and poor peripheral circulation were also common findings. Because of the feeding history (including iron supplement), the ages of the babies, and the slightly high reticulocyte count for age, I should like to see studies (such as hydrogen peroxide test and vitamin E levels) to exclude vitamin E deficiency. It is well known that megaloblastic changes of erythroid precursors occur in haemolytic anaemias regardless of the cause.
